Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
1.240
+0.100 (8.77%)
At close: Nov 7, 2024, 4:00 PM
1.210
-0.030 (-2.42%)
After-hours: Nov 7, 2024, 4:50 PM EST

Rapid Micro Biosystems Revenue

Rapid Micro Biosystems had revenue of $7.60M in the quarter ending September 30, 2024, with 23.74% growth. This brings the company's revenue in the last twelve months to $26.17M, up 27.31% year-over-year. In the year 2023, Rapid Micro Biosystems had annual revenue of $22.52M with 31.44% growth.

Revenue (ttm)
$26.17M
Revenue Growth
+27.31%
P/S Ratio
1.89
Revenue / Employee
$135,596
Employees
193
Market Cap
53.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.15M44.50%
Dec 31, 202016.08M-435.00K-2.63%
Dec 31, 201916.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortress Biotech 82.62M
Allurion Technologies 47.59M
Cytosorbents 37.16M
Prenetics Global 22.66M
iCAD, Inc. 18.80M
SCYNEXIS 8.57M
LAVA Therapeutics 7.40M
OncoCyte 1.02M
Revenue Rankings